Skip to main content
Ams Channel
WORLD2026-03-1014:51:35 UTC

Novo Nordisk is warned by the FDA for failing to report side effects

Editorial Staff · 1 min read

Summary

  • Summary pending editorial review.

Key Facts

  • Key facts pending editorial review.

Sources

Updates

Update at 13:29 UTC on 2026-03-11

STAT reported Recent developments highlight the FDA's warning to Novo Nordisk and Lilly's strategic investments in China.

Sources: STAT